Table 1.
Clinical characteristics of the study population in the control, ACVIM B and ACVIM C groups
| ACVIM stage | ACVIM A–unaffected (mean ± SD) | ACVIM B (mean ± SD) | ACVIM C (mean ± SD) | |
|---|---|---|---|---|
| Numer of dogs | 8 | 8 | 7 | |
| Age range (years) | 5.458 ± 2.51 | 10.17 ± 3.36 | 10.40 ± 4.73 | |
| Sex | Males | 2 | 4 | 5 |
| Females | 6 | 4 | 3 | |
| Body weight (kg) | 10.38 ± 3.26 | 9.46 ± 2.13 | 9.20 ± 1.83 | |
| EF % | 71.25 ± 12.26 | 69.5 ± 8.21 | 77.14 ± 3.39 | |
| LA/Ao | 1.223 ± 0.10 | 1.479 ± 0.41 | 1.774 ± 0.21* | |
| LA cm | 1.938 ± 0.47 | 2.348 ± 0.54 | 2.811 ± 0.32* | |
| LVDd | 2.863 ± 0.24 | 2.993 ± 0.43 | 3.529 ± 0.42** | |
| MVR | 0 | 5.466 ± 1.05*** (n = 5) | 5.963 ± 0.78*** | |
| RVDd | 0.9375 ± 0.17 | 0.9275 ± 0.14 | 0.6057 ± 0.21** | |
| TVR m/s | 0.3988 ± 1.13 | 0.925 ± 1.39 | 2.379 ± 1.19* | |
*statistically significant difference vs healthy dogs with p < 0.05; **statistically significant difference vs healthy dogs with p < 0.01; ***statistically significant difference vs healthy dogs with p < 0.001.